The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantifying the additional prognostic value of sentinel lymph node status over established clinicopathologic primary tumor features for predicting survival outcomes in melanoma patients.
 
Serigne Lo
No Relationships to Disclose
 
Mary-Ann El Sharouni
Honoraria - MSD
Research Funding - European Academy of Dermatology and Venereology
 
Karijn Suijkerbuijk
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst)
Speakers' Bureau - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD (Inst); Roche (Inst)
 
Tasnia Ahmed
No Relationships to Disclose
 
Witkamp Arjen
No Relationships to Disclose
 
Anne E. Cust
No Relationships to Disclose
 
Vigfús Sigurdsson
No Relationships to Disclose
 
Paul J. van Diest
Consulting or Advisory Role - Pantarhei Bioscience (Inst)
Patents, Royalties, Other Intellectual Property - DDX3 as a biomarker for cancer and methods related thereto (Inst)
 
Richard A. Scolyer
Consulting or Advisory Role - Merck Sharp & Dohme; Myriad Pharmaceuticals; NeraCare GmbH; Novartis
 
Carla Van Gils
Consulting or Advisory Role - Bayer
Research Funding - Bayer
 
John F. Thompson
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD Australia; Provectus
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD Australia; Provectus
Travel, Accommodations, Expenses - GlaxoSmithKline; Provectus